MoonLake Immunotherapeutics Class A Share Price

MoonLake Immunotherapeutics Class A Share Price

NASDAQ: MLTX | Small Cap
$11.78
-$0.79 (-6.32%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MoonLake Immunotherapeutics Class A Stock Performance

Open
$12.58
Prev. Close
$12.57
Circuit Range
N/A
Day Range
$11.72 - $12.58
Year Range
$9.47 - $23.25
Volume
78,026
Average Traded
$12.10

MoonLake Immunotherapeutics Class A Share Price Today

As of 31 October 2026, MoonLake Immunotherapeutics Class A's share price is $11.78. The stock opened at $12.58, compared to its previous close of $12.57. During today's trading session, MoonLake Immunotherapeutics Class A's share price traded between $11.72 and $12.58, with an average price of $12.15. Over the past 52 weeks, the stock has recorded a high of $23.25 and a low of $9.47. In terms of performance, MoonLake Immunotherapeutics Class A's share price has declined by 27.91% over the last six months and is up 16.98% on a year-on-year basis.

MoonLake Immunotherapeutics Class A Share Price Chart

Line chart of the MoonLake Immunotherapeutics Class A price trend over the selected period. The price fell overall, ranging from 11.73 to 12.39, ending at 11.79.
$11.72$12.58
L
Show Current Price
H

MoonLake Immunotherapeutics Class A Stock Fundamentals & Key Indicators

Market Cap
$759.38M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.08
Revenue (TTM)
$0.00
Return On Equity (TTM)
-61.24%
Profit Margin
N/A
Debt to Equity
0.23
Quarterly Earnings Growth YoY
12.56%

MoonLake Immunotherapeutics Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$70.69-$60.02-$69.71-$61.81
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A15.09%-16.14%11.33%

MoonLake Immunotherapeutics Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$49.97-$36.01-$118.94-$227.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A27.94%-230.30%-91.12%

About MoonLake Immunotherapeutics Class A

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

MoonLake Immunotherapeutics Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$11.69
$11.77
+0.34%
Sep 2026
$15.05
$11.72
-24.55%
Aug 2026
$18.37
$15.54
-15.75%
Jul 2026
$19.75
$18.45
-5.26%
Jun 2026
$18.91
$19.47
+1.54%
May 2026
$16.37
$19.18
+17.35%
Apr 2026
$17.29
$16.34
-12.29%
Mar 2026
$17.29
$18.63
+6.34%
Feb 2026
$16.35
$17.52
+11.84%
Jan 2026
$13.19
$15.66
+18.99%
Dec 2025
$13.59
$13.16
-4.25%
Nov 2025
$10.37
$13.75
+36.54%

MLTX Share Price FAQs